Skip to main content
. 2022 Jul 1;19:55. doi: 10.1186/s12987-022-00352-w

Table 1.

Demographic overview

Patient category
REF PC AC SIH IIH iNPH Comm. HC Non-comm. HC
Number of subjects 28 13 14 14 15 63 11 3
Ith dose of gadobutrol
 0.10 mmol 0 0 0 0 0 13 0 0
 0.25 mmol 3 0 2 4 1 17 3 0
 0.50 mmol 25 13 12 10 14 33 8 3
Gender (male/female) 6/22 1/12 8/6a 5/9 2/13 37/26b 7/4a 2/1
Age (years) 39 ± 12 36 ± 13 52 ± 17a 50 ± 10b 33 ± 11 72 ± 6c 49 ± 13a 43 ± 29
Height (cm) 172 ± 8 170 ± 5 176 ± 10 172 ± 10 165 ± 7b 173 ± 9 178 ± 12 171 ± 7
Weight (kg) 82 ± 15 80 ± 15 82 ± 13 78 ± 23 88 ± 17 81 ± 16 84 ± 20 80 ± 24
BMI (kg/m2) 28 ± 5 28 ± 4 27 ± 3 26 ± 6 32 ± 5a 27 ± 4 26 ± 5 27 ± 6
GFR (ml/min) 103 ± 12 98 ± 12 86 ± 16b 95 ± 15 105 ± 13 77 ± 14c 92 ± 18 104 ± 15

Data presented as mean ± SD. Differences from the reference group were determined by independent samples t-test for continuous variables and by Fishers exact test for categorical variables (aP < 0.05, bP < 0.01, cP < 0.001). Patient categories: AC Arachnoid cyst, Comm HC communicating hydrocephalus, IIH idiopathic intracranial hypertension, iNPH idiopathic normal pressure hydrocephalus, Non-comm HC non-communicating hydrocephalus, PC pineal cyst, REF reference cohort, SIH spontaneous intracranial hypotension